Literature DB >> 22118899

Depression and care-dependency in Parkinson's disease: results from a nationwide study of 1449 outpatients.

O Riedel1, R Dodel, G Deuschl, J Klotsche, H Förstl, I Heuser, W Oertel, H Reichmann, P Riederer, C Trenkwalder, H-U Wittchen.   

Abstract

Parkinson's disease (PD) is frequently compounded by neuropsychiatric complications, increasing disability. The combined effect of motor and mental status on care-dependency in PD outpatients is not well characterized. We conducted a cross-sectional study of 1449 PD outpatients. The assessment comprised the Montgomery-Asberg Depression Rating Scale (MADRS) and the diagnostic criteria for dementia. PD severity and treatment complications were rated using Hoehn and Yahr staging and the Unified Parkinson's Disease Rating Scale (UPDRS) IV. The acknowledged level of care-dependency was documented. Care-dependency was present in 18.3% of all patients. A total of 13.9% had dementia, 18.8% had depression, and 14.3% had both. Regression analyses revealed increasing effects of age, PD duration, and PD severity on care-dependency in all three mental-disorder subgroups with the strongest effects in patients with depression only. Depressed patients with antidepressive treatment still had significantly higher PD severity, higher MADRS and UPDRS-IV scores but were not more likely to be care-dependent than non-depressed patients. Older age, longer duration and increased severity of PD contribute to care-dependency in patients with untreated depression. Treatment of depression is associated with lower rates of care-dependency.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22118899     DOI: 10.1016/j.parkreldis.2011.11.007

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  7 in total

Review 1.  Safety and Tolerability of Pharmacotherapies for Parkinson's Disease in Geriatric Patients.

Authors:  Martin Klietz; Stephan Greten; Florian Wegner; Günter U Höglinger
Journal:  Drugs Aging       Date:  2019-06       Impact factor: 3.923

Review 2.  Anxiety in Parkinson's disease: identification and management.

Authors:  Jack J Chen; Laura Marsh
Journal:  Ther Adv Neurol Disord       Date:  2014-01       Impact factor: 6.570

3.  Psychometric properties of the apathy evaluation scale in patients with Parkinson's disease.

Authors:  Ulrike Lueken; Ricarda Evens; Monika Balzer-Geldsetzer; Simon Baudrexel; Richard Dodel; Susanne Gräber-Sultan; Rüdiger Hilker-Roggendorf; Elke Kalbe; Oliver Kaut; Brit Mollenhauer; Kathrin Reetz; Eva Schäffer; Nele Schmidt; Jörg B Schulz; Annika Spottke; Karsten Witt; Katharina Linse; Alexander Storch; Oliver Riedel
Journal:  Int J Methods Psychiatr Res       Date:  2017-04-18       Impact factor: 4.035

4.  Development of screening batteries for neuropsychiatric comorbidity in elderly.

Authors:  Yaroslav Winter; Natalia Epifanova-Bertschi; Alexei Korchounov
Journal:  J Neurosci Rural Pract       Date:  2013-08

Review 5.  The recommendations of Chinese Parkinson's disease and movement disorder society consensus on therapeutic management of Parkinson's disease.

Authors:  Shengdi Chen; Piu Chan; Shenggang Sun; Haibo Chen; Baorong Zhang; Weidong Le; Chunfeng Liu; Guoguang Peng; Beisha Tang; Lijuan Wang; Yan Cheng; Ming Shao; Zhenguo Liu; Zhenfu Wang; Xiaochun Chen; Mingwei Wang; Xinhua Wan; Huifang Shang; Yiming Liu; Pingyi Xu; Jian Wang; Tao Feng; Xianwen Chen; Xingyue Hu; Anmu Xie; Qin Xiao
Journal:  Transl Neurodegener       Date:  2016-06-30       Impact factor: 8.014

6.  Anxiety and anxious-depression in Parkinson's disease over a 4-year period: a latent transition analysis.

Authors:  S Landau; V Harris; D J Burn; J V Hindle; C S Hurt; M Samuel; K C Wilson; R G Brown
Journal:  Psychol Med       Date:  2015-10-23       Impact factor: 7.723

7.  Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson's Disease.

Authors:  Veronica Antipova; Carsten Holzmann; Alexander Hawlitschka; Martin Witt; Andreas Wree
Journal:  Toxins (Basel)       Date:  2021-07-20       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.